News
Princeton inviting DDi
PRINCETON, NJ – April 19, 2015 – In a significant move aimed at scaling its global operations, DDi (Drug Development informatics) has officially announced the relocation and expansion of its corporate headquarters to Princeton, New Jersey. This strategic transition marks a pivotal chapter in the company’s growth, positioning it at the heart of the world’s most prominent pharmaceutical and life sciences corridor.
The move to the new, larger office space in Princeton is a direct response to the increasing demand for DDi’s innovative clinical and regulatory technology solutions. By establishing its headquarters in this premier biotech hub, DDi aims to foster closer collaborations with industry leaders and tap into the region’s rich talent pool of clinical research and technology experts.
“Princeton is inviting DDi into a community synonymous with innovation,” said a company executive. “This expansion is not just about a new address; it is about scaling our infrastructure to better serve our global clients with AI-driven clinical data management and automated regulatory solutions.”
As DDi continues to disrupt the drug development landscape with its “smart” technology suites, the Princeton headquarters will serve as the central nerve center for its future research, development, and global business expansion initiatives.
Let's talk about how DDi can help you